Your browser doesn't support javascript.
Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic.
Fletcher, Monica; van der Molen, Thys; Lenney, Warren; Boucot, Isabelle; Aggarwal, Bhumika; Pizzichini, Emilio.
  • Fletcher M; The Usher Institute, University of Edinburgh, Edinburgh, UK. Monica.Fletcher@ed.ac.uk.
  • van der Molen T; Department of General Practice and GRIAG Research Institute, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Lenney W; Department of Pharmacy and Bioengineering, University of Keele, Keele, Staffordshire, UK.
  • Boucot I; Respiratory, GlaxoSmithKline, Brentford, London, UK.
  • Aggarwal B; Respiratory, General Medicines Emerging Markets, GlaxoSmithKline, Singapore, 139234, Singapore.
  • Pizzichini E; Respiratory, GlaxoSmithKline, Brentford, London, UK.
Adv Ther ; 39(4): 1457-1473, 2022 04.
Article in English | MEDLINE | ID: covidwho-1681941
ABSTRACT
The COVID-19 pandemic has brought a renewed focus on appropriate management of chronic respiratory conditions with a heightened awareness of respiratory symptoms and the requirement for differential diagnosis between an asthma attack and COVID-19 infection. Despite early concerns in the pandemic, most studies suggest that well-managed asthma is not a risk factor for more severe COVID-related outcomes, and that asthma may even have a protective effect. Advice on the treatment of asthma and asthma attacks has remained unchanged. This article describes some challenges faced in primary care asthma management in adults and in teenagers, particularly their relevance during a pandemic, and provides practical advice on asthma attack recognition, classification, treatment and continuity of care. Acute attacks, characterised by increased symptoms and reduced lung function, are often referred to as exacerbations of asthma by doctors and nurses but are usually described by patients as asthma attacks. They carry a significant and underestimated morbidity and mortality burden. Many patients experiencing an asthma attack are assessed in primary care for treatment and continuing management. This may require remote assessment by telephone and home monitoring devices, where available, during a pandemic. Differentiation between an asthma attack and a COVID-19 infection requires a structured clinical assessment, taking account of previous medical and family history. Early separation into mild, moderate, severe or life-threatening attacks is helpful for continuing good management. Most attacks can be managed in primary care but when severe or unresponsive to initial treatment, the patient should be appropriately managed until transfer to an acute care facility can be arranged. Good quality care is important to prevent further attacks and must include a follow-up appointment in primary care, proactive regular dosing with daily controller therapy and an understanding of a patient's beliefs and perceptions about asthma to maximise future self-management.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Prognostic study Limits: Adolescent / Adult / Humans Language: English Journal: Adv Ther Journal subject: Therapeutics Year: 2022 Document Type: Article Affiliation country: S12325-022-02056-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Prognostic study Limits: Adolescent / Adult / Humans Language: English Journal: Adv Ther Journal subject: Therapeutics Year: 2022 Document Type: Article Affiliation country: S12325-022-02056-x